NCT01263470
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Okayama, Japan
Clinical trial condition
Diabetes Mellitus
Explore clinical trials studying Diabetes Mellitus. Study availability and eligibility vary by location and protocol.
6,402 public trials
530 recruiting studies
Diabetes Mellitus trial results
NCT01263496
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT00286494
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
- Locations
-
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Anaheim, California, United States
- Artesia, California, United States
Completed
Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.
NCT00708175
- Conditions
- Bone Metabolism, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Greenbrae, California, United States
- Los Banos, California, United States
- San Diego, California, United States
- Walnut Creek, California, United States
NCT00286468
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
- Locations
-
- Birmingham, Alabama, United States
- Peoria, Arizona, United States
- Phoenix, Arizona, United States
- Anaheim, California, United States
NCT01263509
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT00845897
- Conditions
- Diabetes Mellitus, Endocrine System Diseases, Foot Diseases, +13 more
- Locations
-
- Washington University St Louis, Missouri, United States
NCT01318122
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT00286455
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +5 more
- Locations
-
- Birmingham, Alabama, United States
- Peoria, Arizona, United States
- Phoenix, Arizona, United States
- Anaheim, California, United States
Completed
Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.
NCT00755846
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
Not specified